リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Insomnia in patients with acute heart failure: from the KCHF registry」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。
リケラボ

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Insomnia in patients with acute heart failure: from the KCHF registry

Seko, Yuta Yamamoto, Erika Kato, Takao Morimoto, Takeshi Yaku, Hidenori Inuzuka, Yasutaka Tamaki, Yodo Ozasa, Neiko Shiba, Masayuki Yoshikawa, Yusuke Yamashita, Yugo Kitai, Takeshi Taniguchi, Ryoji Iguchi, Moritake Nagao, Kazuya Kawai, Takafumi Komasa, Akihiro Nishikawa, Ryusuke Kawase, Yuichi Morinaga, Takashi Toyofuku, Mamoru Furukawa, Yutaka Ando, Kenji Kadota, Kazushige Sato, Yukihito Kuwahara, Koichiro Kimura, Takeshi 京都大学 DOI:10.1002/ehf2.14025

2022.10

概要

[Aims] Insomnia is a known risk factor for heart failure (HF) and a predictor of cardiac events in HF patients, but the clinical significance of insomnia in patients with acute HF (AHF) is not adequately evaluated. This study aimed to investigate the association between insomnia and subsequent clinical outcomes in patients with AHF. [Methods] From the Kyoto Congestive Heart Failure registry, consecutive 3414 patients hospitalized for HF who were discharged alive were divided into the 2 groups at discharge: insomnia group and non-insomnia group. We compared baseline characteristics and 1 year clinical outcomes according to the presence of insomnia. The primary outcome measure was all-cause death. [Results] There were 330 patients (9.7%) and 3084 patients (90.3%) with and without insomnia, respectively. In the multivariable logistic regression analysis, brain-type natriuretic peptide above median value at discharge (OR = 1.50, 95% CI = 1.08–2.10, P = 0.02) and the presence of oedema at discharge (OR = 4.23, 95% CI = 2.95–6.07, P < 0.001) were positively associated with insomnia at discharge, whereas diuretics at discharge (OR = 0.60, 95% CI = 0.39–0.90, P = 0.01) were negatively associated with insomnia at discharge. The cumulative 1 year incidence of all-cause death was significantly higher in the insomnia group than in the non-insomnia group (25.1% vs. 16.2%, P < 0.001). Even after adjusting the confounders, the higher mortality risk of patients with insomnia relative to those without insomnia remained significant (HR = 1.55, 95% CI = 1.24–1.94; P < 0.001). [Conclusions] Patients with insomnia at discharge were associated with a higher risk of mortality than those without insomnia at discharge.

論文の公開元へ

この論文で使われている画像

関連論文

関連論文をもっと見る

参考文献

1. Agarwal MA, Fonarow GC, Ziaeian B. National Trends in heart failure hospital- izations and readmissions from 2010 to 2017. JAMA Cardiol. 2021; 6: 952–956.

2. Shiraishi Y, Kohsaka S, Sato N, Takano T, Kitai T, Yoshikawa T, Matsue Y. 9-year trend in the Management of Acute Heart Failure in Japan: A report from the Na- tional Consortium of acute heart failure registries. J Am Heart Assoc. 2018; 7: e008687.

3. Basta M, Chrousos GP, Vela-Bueno A, Vgontzas AN. Chronic insomnia and stress system. Sleep Med Clin. 2007; 2: 279–291.

4. Laugsand LE, Strand LB, Platou C, Vatten LJ, Janszky I. Insomnia and the risk of incident heart failure: A popula- tion study. Eur Heart J. 2014; 35: 1382–1393.

5. Redeker NS, Jeon S, Muench U, Campbell D, Walsleben J, Rapoport DM. Insomnia symptoms and daytime function in stable heart failure. Sleep. 2010; 33: 1210–1216.

6. Riegel B, Moelter ST, Ratcliffe SJ, Pressler SJ, De Geest S, Potashnik S, Fleck D, Sha D, Sayers SL, Weintraub WS, Weaver TE, Goldberg LR. Excessive daytime sleepiness is associated with poor medication adherence in adults with heart failure. J Card Fail. 2011; 17: 340–348.

7. Kanno Y, Yoshihisa A, Watanabe S, Takiguchi M, Yokokawa T, Sato A, Miura S, Shimizu T, Nakamura Y, Abe S, Sato T, Suzuki S, Oikawa M, Saitoh S, Takeishi Y. Prognostic significance of insomnia in heart failure. Circ J. 2016; 80: 1571–1577.

8. Principe-Rodriguez K, Strohl KP, Hadziefendic S, Pina IL. Sleep symptoms and clinical markers of illness in patients with heart failure. Sleep Breath. 2005; 9: 127–133.

9. Yamamoto E, Kato T, Ozasa N, Yaku H, Inuzuka Y, Tamaki Y, Kitai T, Morimoto T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Kawashima T, Motohashi Y, Kawato M, Toyofuku M, Sato Y, Kuwahara K, Shioi T, Kimura T, KCHF study investigators. Kyoto conges- tive heart failure (KCHF) study: Ratio- nale and design. ESC Heart Fail. 2017; 4: 216–223.

10. Yaku H, Ozasa N, Morimoto T, Inuzuka Y, Tamaki Y, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Su K, Kawato M, Sasaki K, Toyofuku M, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Kato T, Kimura T, KCHF Study Investigators. Demographics, management, and in-hospital outcome of hospitalized acute heart failure syndrome patients in contemporary real clinical practice in Japan- observations from the prospec- tive, multicenter Kyoto congestive heart failure (KCHF) registry. Circ J. 2018; 82: 2811–2819.

11. Ministry of Health, Labour and Welfare. Ethical Guidelines for Medical and Health Research Involving Human Sub- jects. https://www.lifescience.mext.go. jp/files/pdf/n2181_01.pdf (11 Novem- ber 2020).

12. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A, Collaborators developing the Japanese equation for es- timated GFR. Revised equations for esti- mated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009; 53: 982–992.

13. Yaku H, Kato T, Morimoto T, Inuzuka Y, Tamaki Y, Ozasa N, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Toyofuku M, Seko Y, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Kimura T, KCHF Study Investigators. Association of Mineralocorticoid Receptor Antagonist use with all-Cause Mortality and Hospi- tal Readmission in older adults with acute decompensated heart failure. JAMA Netw Open. 2019; 2: e195892.

14. Hayes D Jr, Anstead MI, Ho J, Phillips BA. Insomnia and chronic heart failure. Heart Fail Rev. 2009; 14: 171–182.

15. Javaheri S, Redline S. Insomnia and risk of cardiovascular disease. Chest. 2017; 152: 435–444.

16. Gangwisch JE, Heymsfield SB, Boden- Albala B, Buijs RM, Kreier F, Pickering TG, Rundle AG, Zammit GK, Malaspina D. Short sleep duration as a risk factor for hypertension: Analyses of the first National Health and nutrition examina- tion survey. Hypertension. 2006; 47: 833–839.

17. Redeker NS, Jeon S, Andrews L, Cline J, Mohsenin V, Jacoby D. Effects of cogni- tive behavioral therapy for insomnia on sleep-related cognitions among patients with stable heart failure. Behav Sleep Med. 2019; 17: 342–354.

18. Redeker NS, Jeon S, Andrews L, Cline J, Jacoby D, Mohsenin V. Feasibility and ef- ficacy of a self-management interven- tion for insomnia in stable heart failure. J Clin Sleep Med. 2015; 11: 1109–1119.

参考文献をもっと見る